Rethinking Preclinical Testing – The DART Advantage

What if you could rethink preclinical testing — beyond animal models, beyond limitations? Join us for the first episode of our podcast, "Rethinking Preclinical Testing – The DART Advantage," featuring Dr. Subhadra Dravida, Founder & CEO, Transcell Biologics, as the guest speaker, in a powerful conversation with our host, Barinder Marhok, Global Head – Healthcare & Life Sciences, Quantiphi. Discover the Phi Moment – the breakthrough realization that led to DART, an AI-powered, stem cell-based platform that's rewriting the future of preclinical testing: faster, scalable, and more ethical.Visit www.quantiphi.com for more information. Hosted on Acast. See acast.com/privacy for more information.